Breast Cancer Survivor Meets Researcher Who Could Find an Alternative Treatment to Chemotherapy
Source: Pixabay.com

Breast Cancer Survivor Meets Researcher Who Could Find an Alternative Treatment to Chemotherapy

According to a story by the Daily Record UK, Maggie Ritchie found out she was diagnosed with breast cancer and four years later was successfully cancer-free. She attributed the advanced…

Continue Reading Breast Cancer Survivor Meets Researcher Who Could Find an Alternative Treatment to Chemotherapy
Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test
Free-Photos / Pixabay

Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test

According to a story from Scleroderma News, the results from a recent study suggest that the six minute walk test can accurately predict outcomes for patients with systemic sclerosis. A…

Continue Reading Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test
Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer
geralt / Pixabay

Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer

The organisations Guerbet and IBM Watson Health are collaborating to develop an artificial intelligence tool designed to support the diagnosis and care of liver cancer. The source article can be…

Continue Reading Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer
A Patient With Waldenström Macroglobulinemia has Shown a Large Reduction in Overall Tumour Volume While Taking Part in a Clinical Trial
valelopardo / Pixabay

A Patient With Waldenström Macroglobulinemia has Shown a Large Reduction in Overall Tumour Volume While Taking Part in a Clinical Trial

A patient with Waldenström Macroglobulinemia taking part in a clinical trial of the experimental drug CLR 131 for the treatment of B-cell hematologic cancers is reported to have achieved a…

Continue Reading A Patient With Waldenström Macroglobulinemia has Shown a Large Reduction in Overall Tumour Volume While Taking Part in a Clinical Trial

Melflufen Could be a New Treatment Option for Multiple Myeloma

According to a story from Hematology Times, a medicine called melflufen, of the alkylating peptide class, appears to be effective in treatment resistant multiple myeloma. In a Phase 2 trial,…

Continue Reading Melflufen Could be a New Treatment Option for Multiple Myeloma

Pulmonary Fibrosis Foundation Launches New PF Health App: Connect Patients to Resources, Providers and Researchers

CHICAGO, July 19, 2018 – The Pulmonary Fibrosis Foundation (PFF) and monARC Bionetworks have partnered to create the mobile app, PF Health, for individuals living with pulmonary fibrosis (PF).  PF Health, now available on Apple App Store (iOS 9.0 or…

Continue Reading Pulmonary Fibrosis Foundation Launches New PF Health App: Connect Patients to Resources, Providers and Researchers
Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment
Source: Pixabay

Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment

According to a story from PR Newswire, the biopharmaceutical company AbbVie has recently announced that it has sent a supplemental New Drug Application to the FDA for its product venetoclax,…

Continue Reading Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment
An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency
Free-Photos / Pixabay

An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Clovis Oncology, Inc. has announced that they have submitted an application to the European Medicines Agency (EMA). The application is to extend the drug Rubraca’s®(rucaparib) marketing authorisation to include maintenance…

Continue Reading An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency
Close Menu